Palforzia
DBV craters on FDA’s peanut allergy immunotherapy rejection
Phil Taylor
Aimmune, DBV Technologies, fda, Palforzia, peanut allergy, Viaskin Peanut
0 Comment
X
DBV craters on FDA’s peanut allergy immunotherapy rejection
https://pharmaphorum.com/news/dbv-craters-on-fdas-peanut-allergy-immunotherapy-rejection/
FDA approves first ever peanut allergy therapy from Aimmune
Richard Staines
Aimmune, Palforzia, peanut allergy
0 Comment
X
FDA approves first ever peanut allergy therapy from Aimmune
https://pharmaphorum.com/news/fda-approves-first-ever-peanut-allergy-therapy-from-aimmune/